Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
Li, Yixing, Rosenblit, Paul D.Volume:
20
Language:
english
Journal:
Current Cardiology Reports
DOI:
10.1007/s11886-018-1051-2
Date:
November, 2018
File:
PDF, 1.09 MB
english, 2018